Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Gisela Isasi-Rivas"'
Autor:
Doris Villanueva-Pérez, Luis Tataje-Lavanda, Angela Montalván-Avalos, Diego Paredes-Inofuente, Suly Montoya-Ortiz, Gisela Isasi-Rivas, María F. Fernández, Manolo Fernández-Sánchez, Manolo Fernández-Díaz
Publikováno v:
Viruses, Vol 16, Iss 9, p 1463 (2024)
Infectious Bronchitis Virus (IBV) is a major threat to the poultry industry worldwide, causing significant economic losses. While the virus’s genetic structure is well understood, the specific strains circulating in Bolivia have remained uncharacte
Externí odkaz:
https://doaj.org/article/65063b99a47c4b3390e75e170336130d
Autor:
Manolo Fernández Díaz, Katherine Calderón, Aldo Rojas-Neyra, Vikram N. Vakharia, Ricardo Choque-Guevara, Angela Montalvan-Avalos, Astrid Poma-Acevedo, Dora Rios-Matos, Andres Agurto-Arteaga, Maria de Grecia Cauti-Mendoza, Norma Perez-Martinez, Gisela Isasi-Rivas, Luis Tataje-Lavanda, Yacory Sernaque-Aguilar, Freddy Ygnacio, Manuel Criollo-Orozco, Edison Huaccachi-Gonzalez, Elmer Delgado-Ccancce, Doris Villanueva-Pérez, Ricardo Montesinos-Millán, Kristel Gutiérrez-Manchay, Katherinne Pauyac-Antezana, Ingrid Ramirez-Ortiz, Stefany Quiñones-Garcia, Yudith Cauna-Orocollo, Katherine Vallejos-Sánchez, Angela Rios-Angulo, Dennis Núñez-Fernández, Mario I. Salguedo-Bohorquez, Julio Ticona, Manolo Fernández-Sánchez, Eliana Icochea, Luis A. Guevara-Sarmiento, Mirko Zimic, COVID-19 Working Group in Perú
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-18 (2022)
Abstract The coronavirus disease-19 (COVID-19) pandemic has already claimed millions of lives and remains one of the major catastrophes in the recorded history. While mitigation and control strategies provide short term solutions, vaccines play criti
Externí odkaz:
https://doaj.org/article/696e9de1515149608bd5186f685f0c3b
Autor:
Andres Agurto-Arteaga, Astrid Poma-Acevedo, Dora Rios-Matos, Ricardo Choque-Guevara, Ricardo Montesinos-Millán, Ángela Montalván, Gisela Isasi-Rivas, Yudith Cauna-Orocollo, María de Grecia Cauti-Mendoza, Norma Pérez-Martínez, Kristel Gutierrez-Manchay, Ingrid Ramirez-Ortiz, Dennis Núñez-Fernández, Mario I. Salguedo-Bohorquez, Stefany Quiñones-Garcia, Manolo Fernández Díaz, Luis A. Guevara Sarmiento, Mirko Zimic, COVID-19 Working Group in Perú, Ricardo Antiparra, Manuel Ardiles-Reyes, Katherine Calderón, Maria de Grecia Cauti-Mendoza, Naer Chipana-Flores, Xiomara Chunga-Girón, Manuel Criollo-Orozco, Lewis De La Cruz, Nicolás E. Delgado-Pease, Elmer Delgado-Ccancce, Christian Elugo-Guevara, Manolo Fernández-Díaz, Manolo Fernández-Sánchez, Luis Guevara-Sarmiento, Kristel Gutiérrez, Oscar Heredia-Almeyda, Edison Huaccachi-Gonzalez, Pedro Huerta-Roque, Eliana Icochea, Gabriel Jiménez-Avalos, Romina A. Juscamaita-Bartra, Abraham Licla-Inca, Angela Montalván, Adiana Ochoa-Ortiz, Gustavo E. Olivos-Ramirez, Erika Páucar-Montoro, Kathy Pauyac, Jose L. Perez-Martinez, Norma Pérez-M, Daniel Ramos-Sono, Angela A. Rios-Angulo, Aldo Rojas-Neyra, Yomara K. Romero, Yacory Sernaque-Aguilar, Patricia Sheen-Cortavarrı́a, Luis F. Soto, Luis Tataje-Lavanda, Julio Ticona, Katherine Vallejos-Sánchez, A. Paula Vargas-Ruiz, Doris Villanueva-Pérez, Freddy Ygnacio-Aguirre, Mirko Zimic-Peralta
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Within the framework of the current COVID-19 pandemic, there is a race against time to find therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and partially available for low-income countries, passive immunity ba
Externí odkaz:
https://doaj.org/article/b87b2f7e669c4f6f8d6f5e8c60f85c40
Autor:
Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos-Millán, Dora Rios-Matos, Kristel Gutiérrez-Manchay, Angela Montalvan-Avalos, Stefany Quiñones-Garcia, Maria de Grecia Cauti-Mendoza, Andres Agurto-Arteaga, Ingrid Ramirez-Ortiz, Manuel Criollo-Orozco, Edison Huaccachi-Gonzales, Yomara K. Romero, Norma Perez-Martinez, Gisela Isasi-Rivas, Yacory Sernaque-Aguilar, Doris Villanueva-Pérez, Freddy Ygnacio, Katherine Vallejos-Sánchez, Manolo Fernández-Sánchez, Luis A. Guevara-Sarmiento, Manolo Fernández-Díaz, Mirko Zimic, for the COVID-19 Working Group in Perú
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, the emergence of new variants of the virus lead to the generation of new alternatives to improve the current sub-unit vaccines in developm
Externí odkaz:
https://doaj.org/article/3477e42e168247488176f353af1a1169
Autor:
Luis M. Jara, Cusi Ferradas, Francesca Schiaffino, Camila Sánchez-Carrión, Ana Martínez-Vela, Alexandra Ulloa, Gisela Isasi-Rivas, Angela Montalván, Luis Guevara Sarmiento, Manolo Fernández, Mirko Zimic
Publikováno v:
One Health, Vol 13, Iss , Pp 100318- (2021)
SARS-CoV-2 can infect a variety of wild and domestic animals worldwide. Of these, domestic cats are highly susceptible species and potential viral reservoirs. As such, it is important to investigate disease exposure in domestic cats in areas with act
Externí odkaz:
https://doaj.org/article/cc6aa1a3afa3407995ab88a5ed277869
Autor:
Katherine Calderón, Aldo Rojas-Neyra, Brigith Carbajal-Lévano, Luis Luján-Valenzuela, Julio Ticona, Gisela Isasi-Rivas, Angela Montalvan, Manuel Criollo-Orozco, Edison Huaccachi-Gonzáles, Luis Tataje-Lavanda, Karla Lucia F. Alvarez, Manolo Fernández-Sánchez, Manolo Fernández-Díaz, Na Tang, Yongxiu Yao, Venugopal Nair
Publikováno v:
Viruses, Vol 14, Iss 4, p 793 (2022)
In this study, we developed a new recombinant virus rHVT-F using a Turkey herpesvirus (HVT) vector, expressing the fusion (F) protein of the genotype XII Newcastle disease virus (NDV) circulating in Peru. We evaluated the viral shedding and efficacy
Externí odkaz:
https://doaj.org/article/acde756da1d44f4485431866550e194f
Autor:
Manolo Fernández-Díaz, Doris Villanueva-Pérez, Luis Tataje-Lavanda, Angela Montalvan-Avalos, Gisela Isasi-Rivas, Milagros Lulo-Vargas, Manolo Fernández-Sánchez
Publikováno v:
Microbiology Resource Announcements.
Surveillance helps us identify and monitor strains with zoonotic potential. A tracheal swab from a pelican on a Peruvian beach was H5N1 positive (clade 2.3.4.4b) using Oxford Nanopore’s MinION platform. The near-complete genome sequence of strain V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84fa26568fed7dbad484c3f06bbf1235
https://doi.org/10.1128/mra.00199-23
https://doi.org/10.1128/mra.00199-23
Autor:
Manolo Fernández-Díaz, Angela Montalván-Avalos, Gisela Isasi-Rivas, Doris Villanueva-Pérez, Stefany Quiñones-Garcia, Luis Tataje-Lavanda, Dora Rios-Matos, Milagros Lulo-Vargas, Manolo Fernández-Sánchez, Luis A. Guevara-Sarmiento, Mirko Zimic, Aldo Rojas-Neyra, Katherine Calderón
Publikováno v:
Microbiology Resource Announcements. 12
This study presents a draft genome sequence of a Newcastle disease virus (NDV) strain (VFAR-136) isolated from a fighting cock ( Gallus gallus ) in the south of Peru. Strain VFAR-136 is a new report of NDV genotype VII circulating in Peru.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23f4e85eba5540342566c1bb19f48667
https://doi.org/10.1128/mra.01293-22
https://doi.org/10.1128/mra.01293-22
Autor:
Ingrid Ramirez-Ortiz, Manuel Criollo-Orozco, Gisela Isasi-Rivas, Yacory Sernaque-Aguilar, Angela Montalvan, Andres Agurto-Arteaga, Luis Raez Guevara, Norma Perez-Martinez, Mirko Zimic, Maria de Grecia Cauti-Mendoza, Yomara K. Romero Lazaro, Dora Rios-Matos, Edison Huaccachi-Gonzales, Kristel Gutierrez-Manchay, Ricardo Choque-Guevara, Stefany Quinones-Garcia, Manolo Fernández-Díaz, Doris Villanueva-Perez, Ricardo Montesinos-Millan, Katherine Vallejos-Sánchez, Manolo Fernández-Sánchez, Astrid Poma-Acevedo
COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, the emergence of new variants of the virus requires new immunization strategies in addition to the current vaccines approved for human adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33786fbfcf245428c86b15f9ea947ceb
https://doi.org/10.1101/2021.11.26.470043
https://doi.org/10.1101/2021.11.26.470043
Autor:
Dora Rios-Matos, Astrid Poma-Acevedo, Vikram N. Vakharia, Ricardo Choque-Guevara, Yudith Cauna-Orocollo, Manolo Fernandez Díaz, Stefany Quinones-Garcia, Katherine Vallejos-Sánchez, Dennis Núñez-Fernández, Manolo Fernández-Sánchez, Norma Perez-Martinez, Yacory Sernaque-Aguilar, Elmer Delgado-Ccancce, Katherine Pauyac-Antezana, Mario I. Salguedo-Bohorquez, Andres Agurto Arteaga, Ricardo Montesinos-Millan, Kristel Gutierrez-Manchay, Doris Villanueva-Perez, Luis Guevara-Sarmiento, Ingrid Ramirez-Ortiz, Mirko Zimic, Freddy Ygnacio-Aguirre, Julio Ticona, Manuel Criollo-Orozco, Angela Montalvan, Angela A. Rios-Angulo, Edison Huaccachi-Gonzalez, Maria de Grecia Cauti-Mendoza, Gisela Isasi-Rivas, Katherine Calderón, Luis Tataje-Lavanda, Aldo Rojas-Neyra, Eliana Icochea
The COVID-19 pandemic has claimed the lives of millions of people. Vaccination is a critical tool for the control of transmission; however, the recent emergence of potentially vaccine-resistant variants renders it important to have a range of vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb3aca340bc4769be594cadf1a7d575
https://doi.org/10.21203/rs.3.rs-420780/v1
https://doi.org/10.21203/rs.3.rs-420780/v1